Cargando…

Emergency Surgery for Metastatic Melanoma

Visceral metastases from malignant melanoma (stage M1c) confer a very poor prognosis, as documented on the most recent revised version of the TNM/AJCC staging system. Emergency surgery for intra-abdominal complications from the disease is rare. We report on our 5-year single institution experience w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantas, Dimitrios, Tsaparas, Petros, Charalampoudis, Petros, Gogas, Helen, Kouraklis, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228804/ https://www.ncbi.nlm.nih.gov/pubmed/25530876 http://dx.doi.org/10.1155/2014/987170

Ejemplares similares

A Case of Retroperitoneal Castleman's Disease and an Update on the Latest Evidence
por: Spartalis, Eleftherios, et al.
Publicado: (2014)

Early Experience in Starting a Laparoscopic Liver Resection Program in Greece
por: Sotiropoulos, Georgios C., et al.
Publicado: (2017)

Inflammatory Myofibroblastic Tumor of the Breast
por: Markopoulos, Christos, et al.
Publicado: (2015)

The value of staging laparoscopy in gastric cancer
por: Machairas, Nikolaos, et al.
Publicado: (2017)

Right Lower Quadrant Abdominal Pain in a Patient with Prior Ventriculoperitoneal Shunting: Consider the Tip!
por: Charalampoudis, Petros
Publicado: (2012)

Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment
por: Ziogas, Dimitrios C., et al.
Publicado: (2023)

Lack of clinical efficacy of imatinib in metastatic melanoma
por: Ugurel, S, et al.
Publicado: (2005)

Neglected Papillary Thyroid Carcinoma Seven Years after Initial Diagnosis
por: Spartalis, Eleftherios D., et al.
Publicado: (2013)

Multichamber Involvement of Metastatic Cardiac Melanoma
por: Bonou, Maria S., et al.
Publicado: (2022)

Treatment Patterns in Patients with Metastatic Melanoma: A Retrospective Analysis
por: Zhao, Zhongyun, et al.
Publicado: (2014)

Phase II trial of imatinib mesylate in patients with metastatic melanoma
por: Kim, K B, et al.
Publicado: (2008)

Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
por: Tas, Faruk
Publicado: (2012)

Dabrafenib in metastatic melanoma: a monocentric ‘real life’ experience
por: Cocorocchio, E, et al.
Publicado: (2016)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

An overview of antibody–drug conjugates in oncological practice
por: Theocharopoulos, Charalampos, et al.
Publicado: (2020)

Evaluating PSA Density as a Predictor of Biochemical Failure after Radical Prostatectomy: Results of a Prospective Study after a Median Follow-Up of 36 Months
por: Sfoungaristos, Stavros, et al.
Publicado: (2013)

Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy – a longitudinal study
por: Harvie, M N, et al.
Publicado: (2005)

Role of minimally invasive surgery in the treatment of gallbladder metastatic melanoma. A review of the literature and a case report
por: Bangeas, Petros Ioannis, et al.
Publicado: (2022)

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
por: Algazi, A P, et al.
Publicado: (2012)

Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma
por: DeConti, R C, et al.
Publicado: (2010)

Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma
por: Klein, M., et al.
Publicado: (2013)

The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
por: Daly, Louise E, et al.
Publicado: (2017)

Granulomatous colitis in a patient with metastatic melanoma under immunotherapy: a case report and literature review
por: Sakellariou, Stratigoula, et al.
Publicado: (2021)

Nonfunctioning symptomatic paraganglioma: Is there an optimal follow-up for patients with extra-adrenal benign paragangliomas
por: Mantas, D., et al.
Publicado: (2014)

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma
por: Monk, Paul, et al.
Publicado: (2014)

Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond
por: Theocharopoulos, Charalampos, et al.
Publicado: (2021)

Early Continence Recovery after Preservation of Maximal Urethral Length until the Level of Verumontanum during Radical Prostatectomy: Primary Oncological and Functional Outcomes after 1 Year of Follow-Up
por: Sfoungaristos, Stavros, et al.
Publicado: (2013)

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma
por: Daud, Adil, et al.
Publicado: (2017)

Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer
por: Scott, Takara A., et al.
Publicado: (2012)

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
por: Diem, S, et al.
Publicado: (2016)

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients
por: Loskog, Angelica, et al.
Publicado: (2016)

Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure
por: Gialafos, Elias J., et al.
Publicado: (2008)

Symptomatic Construct Failure after Metastatic Spine Tumor Surgery
por: Kumar, Naresh, et al.
Publicado: (2021)

The Incidence, Management, and Outcome of Penetrating Bladder Injuries in Civilians Resultant from Armed Conflict in Baghdad 2005-2006
por: Petros, Firas G., et al.
Publicado: (2009)

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
por: Schmidt, H, et al.
Publicado: (2005)

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study
por: Mouriaux, F, et al.
Publicado: (2016)

Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab
por: Rogiers, Anne, et al.
Publicado: (2020)

The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study
por: Millward, M J, et al.
Publicado: (2006)

Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events
por: Oswalt, Cameron J., et al.
Publicado: (2022)

Neuromuscular Complications of Targeted Anticancer Agents: Can Tyrosine Kinase Inhibitors Induce Myasthenia Gravis? Getting Answers From a Case Report up to a Systematic Review
por: Ziogas, Dimitrios C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hegmeg5rhk5arqeliffg8nko9d